Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,020.00    -110.00 (-1.54%)
Bid:
7,010.00
Ask:
7,020.00
Spread: 10.00 (0.143%)
Market Cap: £9.41b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Pre-Close Update

27 Sep 2011 07:00

RNS Number : 9474O
Diploma PLC
27 September 2011
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

27 September 2011

 

 

DIPLOMA PLC

PRE-CLOSE STATEMENT

YEAR ENDING 30 SEPTEMBER 2011

 

Diploma PLC, the international group of specialised businesses supplying technical products and services, is today providing the following update on trading for the year ending 30 September 2011.

 

The Group has continued to trade strongly across each of its sectors in the final quarter of the year. Revenues for the year ending 30 September 2011 are expected to be

ca. 25% ahead of those reported last year. After adjusting for currency effects and acquisitions, underlying revenues for the year are expected to have increased by ca. 16%. With operating margins remaining strong, the full year adjusted profit before tax is likely to be at the top end of market expectations. Net cash will be strongly positive, in line with expectations.

 

Although general economic uncertainty over the strength of global markets continues, the Board sees good opportunities for future progress and development, both organically and through carefully selected value-enhancing acquisitions, funded by the Group's strong balance sheet and free cash flow.

 

Bruce Thompson, Group Chief Executive commented:

 

"We are pleased to report that Diploma's strong performance has continued through the second half, further demonstrating the resilience of the Group's business model. The Group is well diversified by geography and activity with an offer based on essential products and services, generally funded by customers' operating rather than capital budgets, and reinforced by first class technical expertise and customer support."

 

 

The Preliminary Results for the year ending 30 September 2011 will be announced on Monday, 21 November 2011. There will be an analyst's presentation of the results at 9.00am, at Haberdashers' Hall, 18 West Smithfield, London, EC1A 9HQ.

 

 

 

 

For further information, please contact:

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

 

 

NOTE TO EDITORS:

 

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 850 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 14% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £330m.

 

 

 

 

 

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGZLDVGGMZM
Date   Source Headline
17th Jan 20184:30 pmRNSResult of AGM
17th Jan 20187:00 amRNSTrading Statement
28th Dec 20174:13 pmRNSDirector/PDMR Shareholding
12th Dec 20173:18 pmRNSHolding(s) in Company
8th Dec 20173:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
20th Nov 20177:00 amRNSFinal Results
25th Oct 201710:00 amRNSHolding(s) in Company
25th Oct 20179:50 amRNSHolding(s) in Company
29th Sep 20174:00 pmRNSDirector Declaration
27th Sep 20177:00 amRNSDirectorate Change
26th Sep 201712:41 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSResult of Statutory Audit Tender
30th Aug 20177:00 amRNSTrading Update
17th Aug 20173:29 pmRNSHolding(s) in Company
16th Jun 20179:00 amRNSHolding(s) in Company
14th Jun 20174:05 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
20th Apr 20177:00 amRNSAcquisition
18th Apr 20179:44 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSTrading Update
23rd Mar 20173:05 pmRNSDirector/PDMR Shareholding
13th Mar 20172:08 pmRNSHolding(s) in Company
16th Feb 20175:10 pmRNSHolding(s) in Company
14th Feb 201711:57 amRNSHolding(s) in Company
1st Feb 20177:00 amRNSCapital Markets Day
18th Jan 20174:34 pmRNSResult of AGM
18th Jan 20177:00 amRNSTrading Statement
9th Jan 201711:30 amRNSHolding(s) in Company
5th Jan 201711:26 amRNSHolding(s) in Company
22nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20163:35 pmRNSDirector Declaration
8th Dec 20163:00 pmRNSAnnual Financial Report & Notice of AGM
30th Nov 20164:00 pmRNSDirector/PDMR Shareholding
21st Nov 20167:00 amRNSFinal Results
19th Oct 20162:57 pmRNSHolding(s) in Company
31st Aug 20167:00 amRNSTrading Statement
15th Aug 20164:00 pmRNSHolding(s) in Company
13th Jun 20164:00 pmRNSNotice of Adoption of FRS 101
16th May 20167:00 amRNSHalf Year Announcement
8th Apr 201611:01 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSTrading Update
9th Mar 20167:00 amRNSAcquisition
17th Feb 201610:08 amRNSHolding(s) in Company
21st Jan 20161:46 pmRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSDirectorate Change
20th Jan 20164:58 pmRNSResult of AGM
20th Jan 20167:00 amRNSFirst Quarter Trading Update
17th Dec 201510:00 amRNSDirector/PDMR Shareholding
11th Dec 201511:38 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.